Skip to content
The People's CodeSearch
Menu

Changes to the Code

H.R. 7212 · Hemp Enforcement, Modernization, and Protection Act ·

In committee · step 2 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

21 U.S.C. § 321 Definitions; generally

+125 −01 of 3 shown
More for 21 U.S.C. § 321
Read § 321Only this section
3 changes the bill asks for here, 1 carried out
  1. Not carried out:

    in paragraph (ff)(1), by striking (other than tobacco) and inserting (other than a cannabinoid hemp product or tobacco);

    The bill points to paragraph (ff) of § 321, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no paragraph (ff) in /us/usc/t21/s321
  2. Not carried out:

    in paragraph (rr)(2), by striking or a combination product described in section 503(g) and inserting a combination product described in section 503(g), or a cannabinoid hemp product under paragraph (uu); and

    The bill points to paragraph (rr) of § 321, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no paragraph (rr) in /us/usc/t21/s321
  3. Carried out:

    by adding at the end the following:(tt) (1) The term “cannabinoid” means a chemical, regardless of its source, that meets one or more of the following criteria: (A) A chemical belonging to any of the following chemical subclasses, including any acid, acetate, salt, ester, ether, derivative, or isomer thereof: (i) …

§ 321(ss)–(zz)

Start of § 321 to (ss) unchanged ·

(1) an infant formula; or

(2) a medical food, as defined in section 360ee(b)(3) of this title.

(tt)

(1) [inserted: The term “cannabinoid” means a chemical, regardless of its source, that meets one or more of the following criteria:]

(A) [inserted: A chemical belonging to any of the following chemical subclasses, including any acid, acetate, salt, ester, ether, derivative, or isomer thereof:]

(i) [inserted: Cannabigerol.]

(ii) [inserted: Cannabichromene.]

(iii) [inserted: Cannabidiol.]

(iv) [inserted: Delta-9 tetrahydrocannabinol.]

(v) [inserted: Delta-8 tetrahydrocannabinol.]

(vi) [inserted: Cannabicyclol.]

(vii) [inserted: Cannabielsoin.]

(viii) [inserted: Cannabinol.]

(ix) [inserted: Cannabinodiol.]

(x) [inserted: Cannabitriol.]

(xi) [inserted: Any cannabinoid that is naturally found in, or produced by, the plant Cannabis sativa L. but is of a different chemical subclass than the subclasses listed in subclauses (i) through (x).]

(xii) [inserted: Any cannabinoid that is not naturally found in or produced by the plant Cannabis sativa L. and can only be created through synthetic means, such as hexahydrocannabinol or tetrahydrocannabinol acetate.]

(B) [inserted: Any chemical, regardless of origin or method of production, that—]

(i) [inserted: is equivalent in chemical structure to a chemical referred to in clause (A); or]

(ii) [inserted: has both a similar terpenophenolic chemical structure and pharmacological effect to a chemical referred to in clause (A).]

(C) [inserted: Any chemical derived from a plant of the genus Cannabis that is a CB–1 or CB–2 receptor agonist or partial agonist.]

(D) [inserted: Any chemical that the Secretary by regulation deems to meet the criteria specified in clause (A), (B), or (C).]

(2) [inserted: The Secretary shall—]

(A) [inserted: maintain, and periodically update through publication on the website of the Department of Health and Human Services, a list of cannabinoid compounds that the Secretary has determined meet the definition of cannabinoid as set forth in subparagraph (1); and]

(B) [inserted: not later than 1 year after the date of the enactment of this paragraph, publish the initial list under clause (A).]

(uu)

(1) [inserted: The term “cannabinoid hemp product” means, except as provided in subparagraph (2), any article, including its components or parts, that contains or purports to contain one or more cannabinoids on the list maintained by the Secretary under paragraph (tt)(2) that is intended for use in or on the body of humans or animals.]

(2) [inserted: The term “cannabinoid hemp product” does not include the following:]

(A) [inserted: A drug that is the subject of an application approved under subsection (c) or (j) of section 505 or sections 512 or 571, or is an indexed drug under 572.]

(B) [inserted: A drug that is the subject of an application that has been authorized for investigation pursuant to section 505(i) only to the extent it is being used for such investigation, or a drug intended solely for investigational use that conforms to the terms of an exemption in effect under section 512(j) only to the extent it is being used for such investigation.]

(C) [inserted: A drug that may lawfully be marketed pursuant to section 505G.]

(D) [inserted: A biological product that is subject to an approved biologics license application under section 351 of the Public Health Service Act or licensed under the virus, serum, toxin, and analogous products provisions of the Act of Congress approved March 4, 1913 (21 U.S.C. 151).]

(E) [inserted: A device that may lawfully be marketed pursuant to section 510(k), 513, or 515.]

(F) [inserted: A food additive for which there is in effect a regulation issued under section 409 prescribing the conditions under which such additive may be safely used, if the additive’s use or intended use is in conformity with such regulation.]

(G) [inserted: Any cannabis plant actively under cultivation that is being cultivated in accordance with the requirements of subtitle G of the Agricultural Marketing Act of 1946 (7 U.S.C. 1639o et seq.).]

(vv)

(1) [inserted: The term “inhalable cannabinoid hemp product” means a cannabinoid hemp product intended to be delivered to the respiratory tract by oral inhalation, such as by smoking, combusting, or aerosolizing, and regardless of whether done through the use of a device, including devices such as vaporizers.]

(2) [inserted: Such term includes any component, part, or accessory thereof.]

(ww)

(1) [inserted: The term “oral cannabinoid hemp product” means a cannabinoid hemp product intended for oral consumption through ingestion, sublingual absorption, or buccal absorption.]

(2) [inserted: Such term includes an edible product, a beverage, a tincture, an oil, a tablet, a capsule, an oral pouch, a softgel, and a gelcap.]

(3) [inserted: Such term does not include a topical product or product for inhalation.]

(xx)

(1) [inserted: The term ‘prohibited cannabinoid product’ means, except as provided in subparagraph (2), any product for human or animal use that meets one or more of the following criteria:]

(A) [inserted: In the case of an oral cannabinoid hemp product, the product contains or purports to contain an amount per serving of total intoxicating cannabinoid content that exceeds the applicable threshold specified under section 1012.]

(B) [inserted: In the case of an oral cannabinoid hemp product, the product contains or purports to contain an amount per package or container of total intoxicating cannabinoid content that exceeds the applicable threshold specified under section 1012.]

(C) [inserted: In the case of a cannabinoid hemp product for inhalation, the material to be inhaled in the product contains or purports to contain more than 0.3 percent on a weight basis of total intoxicating cannabinoid content in the product form for its intended use.]

(D) [inserted: In the case of a cannabinoid hemp product for inhalation that is required under section 1005(e) to utilize a prefilled, nonrefillable cartridge, the cartridge contains or purports to contain an amount of total cannabinoid content that exceeds the applicable threshold specified under section 1012.]

(E) [inserted: In the case of a topical cannabinoid hemp product, the product is, or is intended to be, systemically absorbed through the skin.]

(F) [inserted: In the case of a topical cannabinoid hemp product, the product contains or purports to contain more than 0.3 percent on a weight basis.]

(G) [inserted: The product contains, or purports to contain, a cannabinoid of the type referred to in paragraph (tt)(1)(A)(xii), or another cannabinoid that is not naturally occurring in the plant Cannabis sativa L. or is produced by the plant Cannabis sativa L. only through genetic engineering or other manipulation of the plant.]

(H) [inserted: The product is a cannabinoid hemp product that does not meet the definition of an oral cannabinoid hemp product, inhalable cannabinoid hemp product, or topical cannabinoid hemp product.]

(I) [inserted: The product is a cannabinoid hemp product intended for, used in or on, food-producing animals.]

(2) [inserted: The term “prohibited cannabinoid product” does not include—]

(A) [inserted: any product specified in clauses (A) through (G) of paragraph (uu)(2); and]

(B) [inserted: marijuana as defined in section 102(16) of the Controlled Substances Act.]

(yy) [inserted: The term “topical cannabinoid hemp product” means a cannabinoid hemp product intended to be applied externally to the body or any part thereof.]

(zz) [inserted: The term “total intoxicating cannabinoid content” means the total amount of all chemicals present in a cannabinoid hemp product that satisfy any of the following:]

(1) [inserted: The chemicals meet the criteria of subclause (iv) or (v) of paragraph (tt)(1)(A).]

(2) [inserted: The chemicals are deemed by the Secretary under paragraph (tt)(1)(D) as meeting the criteria specified in paragraph (tt)(1)(B) by reference to—]

(A) [inserted: chemicals meeting the criteria of subclause (iv) or (v) of paragraph (tt)(1)(A); or]

(B) [inserted: hexahydrocannabinols or tetrahydrocannabinols meeting the criteria specified in paragraph (tt)(1)(A)(xii).]

(3) [inserted: Any other chemical that—]

(A) [inserted: the Secretary has deemed to be a cannabinoid under paragraph (tt)(1)(D); and]

(B) [inserted: has, or is marketed to have, a pharmacological effect that is similar to—]

(i) [inserted: chemicals meeting the criteria of subclause (iv) or (v) of paragraph (tt)(1)(A); or]

(ii) [inserted: hexahydrocannabinols or tetrahydrocannabinols meeting the criteria specified in paragraph (tt)(1)(A)(xii).]

21 U.S.C. § 331 Prohibited acts

+15 −01 of 7 shown
More for 21 U.S.C. § 331
Read § 331Only this section
7 changes the bill asks for here, 1 carried out
  1. Not carried out:

    in paragraphs (a), (b), (c), (g), (h), and (k) by inserting cannabinoid hemp product, before or cosmetic each place such term appears;

    The bill points to paragraph (a) of § 331, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no paragraph (a) in /us/usc/t21/s331
  2. Not carried out:

    in paragraph (e), by striking or 920 and inserting 920, or 1011;

    The bill points to paragraph (e) of § 331, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no paragraph (e) in /us/usc/t21/s331
  3. Not carried out:

    in the matter preceding subparagraph (1), by striking or a drug or a biological product for which substantial clinical investigations have been instituted and for which the existence of such investigations has been made public and inserting a drug or a biological product for which substantial clinical investigations have been instituted and for which the existence of such investigations has been made public, or a cannabinoid hemp product;

    The bill points to paragraph (ll) of § 331, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no paragraph (ll) in /us/usc/t21/s331
  4. Not carried out:

    in subparagraph (3)(E), by striking or at the end;

    The bill points to paragraph (ll) of § 331, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no paragraph (ll) in /us/usc/t21/s331
  5. Not carried out:

    in subparagraph (4), by striking the period at the end and inserting ; or; and

    The bill points to paragraph (ll) of § 331, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no paragraph (ll) in /us/usc/t21/s331
  6. Not carried out:

    by adding at the end the following:(5) the finished product is a cannabinoid hemp product that conforms with the requirements of this Act.; and

    The bill points to paragraph (ll) of § 331, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.

    Technical detailtarget not found: no paragraph (ll) in /us/usc/t21/s331
  7. Carried out:

    by adding at the end the following:(jjj) (1) The introduction or delivery for introduction into interstate commerce of a prohibited cannabinoid product; (2) the receipt in interstate commerce of a prohibited cannabinoid product, and the delivery or proffered delivery thereof for pay or otherwise; (3) the doing of …

§ 331(hhh)–(kkk)

Start of § 331 to (ggg)(2) unchanged ·

(hhh) The failure to register or submit listing information in accordance with section 364c of this title.

(iii) The refusal or failure to follow an order under section 364g of this title.

(jjj)

(1) [inserted: The introduction or delivery for introduction into interstate commerce of a prohibited cannabinoid product;]

(2) [inserted: the receipt in interstate commerce of a prohibited cannabinoid product, and the delivery or proffered delivery thereof for pay or otherwise;]

(3) [inserted: the doing of any act with respect to an article, if such act is done while such article is held for sale (whether or not the first sale) after shipment in interstate commerce and results in such article being a prohibited cannabinoid product;]

(4) [inserted: the holding for sale or distribution in interstate commerce of a prohibited cannabinoid product;]

(5) [inserted: the sale by a retailer of a cannabinoid hemp product to any person younger than 21 years of age in violation of section 1007; or]

(6) [inserted: the failure to adhere to uniform manufacturing and testing requirements in accordance with section 1008.]

(kkk) [inserted: The refusal or failure to follow an order under section 1011.]

21 U.S.C. § 333 Penalties

+2 −0Shown
More for 21 U.S.C. § 333
Read § 333Only this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 303(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 333(b)) is amended by adding at the end the following:(9) Enhanced criminal penalties.— Notwithstanding subsection (a), any person who knowingly violates section 301(jjj) shall be imprisoned for not more than 10 years or fined in accordance with title 18, United States Code, or both..

§ 333(b)–(d)

Start of § 333 to (b)(6) unchanged ·

(7) Notwithstanding subsection (a)(2), any person that knowingly and intentionally adulterates a drug such that the drug is adulterated under subsection (a)(1), (b), (c), or (d) of section 351 of this title and has a reasonable probability of causing serious adverse health consequences or death to humans or animals shall be imprisoned for not more than 20 years or fined not more than $1,000,000, or both.

(8) Notwithstanding subsection (a), any person who violates section 331(i)(3) of this title by knowingly making, selling or dispensing, or holding for sale or dispensing, a counterfeit drug, or who violates section 331(fff)(3) of this title by knowingly making, selling or dispensing, or holding for sale or dispensing, a counterfeit device, shall be imprisoned for not more than 10 years or fined in accordance with title 18, or both.

(9) [inserted: Enhanced criminal penalties.—] [inserted: Notwithstanding subsection (a), any person who knowingly violates section 301(jjj) shall be imprisoned for not more than 10 years or fined in accordance with title 18, United States Code, or both.]

(c) Exceptions in certain cases of good faith, etc. No person shall be subject to the penalties of subsection (a)(1) of this section, (1) for having received in interstate commerce any article and delivered it or proffered delivery of it, if such delivery or proffer was made in good faith, unless he refuses to furnish on request of an officer or employee duly designated by the Secretary the name and address of the person from whom he purchased or received such article and copies of all documents, if any there be, pertaining to the delivery of the article to him; or (2) for having violated section 331(a) or (d) of this title, if he establishes a guaranty or undertaking signed by, and containing the name and address of, the person residing in the United States from whom he received in good faith the article, to the effect, in case of an alleged violation of section 331(a) of this title, that such article is not adulterated or misbranded, within the meaning of this chapter designating this chapter or to the effect, in case of an alleged violation of section 331(d) of this title, that such article is not an article which may not, under the provisions of section 344 or 355 of this title, be introduced into interstate commerce; or (3) for having violated section 331(a) of this title, where the violation exists because the article is adulterated by reason of containing a color additive not from a batch certified in accordance with regulations promulgated by the Secretary under this chapter, if such person establishes a guaranty or undertaking signed by, and containing the name and address of, the manufacturer of the color additive, to the effect that such color additive was from a batch certified in accordance with the applicable regulations promulgated by the Secretary under this chapter; or (4) for having violated section 331(b), (c) or (k) of this title by failure to comply with section 352(f) of this title in respect to an article received in interstate commerce to which neither section 353(a) nor 353(b)(1) of this title is applicable, if the delivery or proffered delivery was made in good faith and the labeling at the time thereof contained the same directions for use and warning statements as were contained in the labeling at the time of such receipt of such article; or (5) for having violated section 331(i)(2) of this title if such person acted in good faith and had no reason to believe that use of the punch, die, plate, stone, or other thing involved would result in a drug being a counterfeit drug, or for having violated section 331(i)(3) of this title if the person doing the act or causing it to be done acted in good faith and had no reason to believe that the drug was a counterfeit drug; or (6) for having violated section 331(fff)(2) of this title if such person acted in good faith and had no reason to believe that use of the punch, die, plate, stone, or other thing involved would result in a device being a counterfeit device, or for having violated section 331(fff)(3) of this title if the person doing the act or causing it to be done acted in good faith and had no reason to believe that the device was a counterfeit device.

(d) Exceptions involving misbranded food No person shall be subject to the penalties of subsection (a)(1) of this section for a violation of section 331 of this title involving misbranded food if the violation exists solely because the food is misbranded under section 343(a)(2) of this title because of its advertising.

Rest of § 333 unchanged ·

21 U.S.C. § 334 Seizure

+3 −35 of 7 shown
More for 21 U.S.C. § 334
Read § 334Only this section
7 changes the bill asks for here, 5 carried out
  1. Carried out:

    by striking and (H) and inserting (H); and

  2. Carried out:

    by inserting before the period at the end the following: , (I) Any adulterated or misbranded cannabinoid hemp product, and (J) Any prohibited cannabinoid product;

  3. Carried out:

    by inserting cannabinoid hemp product, before or cosmetic; and

  4. Carried out:

    in the last sentence, by inserting an article in violation of section 301(jjj) or after by reason of its being; and

  5. Carried out:

    by striking the first sentence and inserting the following: If during an inspection conducted under section 704 of a facility or a vehicle, a device, cannabinoid hemp product, or tobacco product, which the officer or employee making the inspection has reason to believe is adulterated or misbranded is found in such facility or vehicle, or the officer or employee making the inspection has reason to believe the product is a prohibited cannabinoid product, such officer or employee may order the device, cannabinoid hemp product, prohibited cannabinoid hemp product, or tobacco product detained (in accordance with regulations prescribed by the Secretary) for a reasonable period which may not exceed twenty days unless the Secretary determines that a period of detention greater than twenty days is required to institute an action under subsection (a) or section 302, in which case he may authorize a detention period of not to exceed thirty days.; and

  6. Not carried out:

    in each of the second, third, and fourth sentences, by striking device or tobacco product each place it appears and inserting device, cannabinoid hemp product, prohibited cannabinoid product, or tobacco product; and

    We can't read how this instruction is worded yet, so it isn't shown in the text.

    Technical detailno-pattern: in each of the second, third, and fourth sentences, by striking QTEXT each place it appears and inserting QTEXT; and
  7. Not carried out:

    in paragraph (2)(A), in the matter preceding clause (i), by striking device or tobacco product and inserting device, cannabinoid hemp product, prohibited cannabinoid product, or tobacco product.

    “device or tobacco product” isn't in § 334(g)(2)(A) in the Code as we have it. The law may have changed since the bill was drafted.

    Technical detail“device or tobacco product” not found in /us/usc/t21/s334/g/2/A

§ 334(a)

§ 334. Seizure

(a) Grounds and jurisdiction

(1) Any article of food, drug, or cosmetic that is adulterated or misbranded when introduced into or while in interstate commerce or while held for sale (whether or not the first sale) after shipment in interstate commerce, or which may not, under the provisions of section 331(ll), 344, or 355 of this title, be introduced into interstate commerce, shall be liable to be proceeded against while in interstate commerce, or at any time thereafter, on libel of information and condemned in any district court of the United States or United States court of a Territory within the jurisdiction of which the article is found. No libel for condemnation shall be instituted under this chapter, for any alleged misbranding if there is pending in any court a libel for condemnation proceeding under this chapter based upon the same alleged misbranding, and not more than one such proceeding shall be instituted if no such proceeding is so pending, except that such limitations shall not apply (A) when such misbranding has been the basis of a prior judgment in favor of the United States, in a criminal, injunction, or libel for condemnation proceeding under this chapter, or (B) when the Secretary has probable cause to believe from facts found, without hearing, by him or any officer or employee of the Department that the misbranded article is dangerous to health, or that the labeling of the misbranded article is fraudulent, or would be in a material respect misleading to the injury or damage of the purchaser or consumer. In any case where the number of libel for condemnation proceedings is limited as above provided the proceeding pending or instituted shall, on application of the claimant, seasonably made, be removed for trial to any district agreed upon by stipulation between the parties, or, in case of failure to so stipulate within a reasonable time, the claimant may apply to the court of the district in which the seizure has been made, and such court (after giving the United States attorney for such district reasonable notice and opportunity to be heard) shall by order, unless good cause to the contrary is shown, specify a district of reasonable proximity to the claimant’s principal place of business, to which the case shall be removed for trial.

(2) The following shall be liable to be proceeded against at any time on libel of information and condemned in any district court of the United States or United States court of a Territory within the jurisdiction of which they are found: (A) Any drug that is a counterfeit drug, (B) Any container of a counterfeit drug, (C) Any punch, die, plate, stone, labeling, container, or other thing used or designed for use in making a counterfeit drug or drugs, (D) Any adulterated or misbranded device, (E) Any adulterated or misbranded tobacco product, (F) Any device that is a counterfeit device, (G) Any container, packaging, or labeling of a counterfeit device, [struck: and ](H) Any punch, die, plate, stone, labeling, container, or other thing used or designed for use in making a counterfeit device or devices[inserted: , (I) Any adulterated or misbranded cannabinoid hemp product, and (J) Any prohibited cannabinoid product].

(3)

(A) Except as provided in subparagraph (B), no libel for condemnation may be instituted under paragraph (1) or (2) against any food which—

§ 334(c)–(d)

(a)(3)(A)(i)–(b) unchanged ·

(c) Availability of samples of seized goods prior to trial The court at any time after seizure up to a reasonable time before trial shall by order allow any party to a condemnation proceeding, his attorney or agent, to obtain a representative sample of the article seized and a true copy of the analysis, if any, on which the proceeding is based and the identifying marks or numbers, if any, of the packages from which the samples analyzed were obtained.

(d) Disposition of goods after decree of condemnation; claims for remission or mitigation of forfeitures

(1) Any food, drug, device, tobacco product, [inserted: cannabinoid hemp product, ]or cosmetic condemned under this section shall, after entry of the decree, be disposed of by destruction or sale as the court may, in accordance with the provisions of this section, direct and the proceeds thereof, if sold, less the legal costs and charges, shall be paid into the Treasury of the United States; but such article shall not be sold under such decree contrary to the provisions of this chapter or the laws of the jurisdiction in which sold. After entry of the decree and upon the payment of the costs of such proceedings and the execution of a good and sufficient bond conditioned that such article shall not be sold or disposed of contrary to the provisions of this chapter or the laws of any State or Territory in which sold, the court may by order direct that such article be delivered to the owner thereof to be destroyed or brought into compliance with the provisions of this chapter, under the supervision of an officer or employee duly designated by the Secretary, and the expenses of such supervision shall be paid by the person obtaining release of the article under bond. If the article was imported into the United States and the person seeking its release establishes (A) that the adulteration, misbranding, or violation did not occur after the article was imported, and (B) that he had no cause for believing that it was adulterated, misbranded, or in violation before it was released from customs custody, the court may permit the article to be delivered to the owner for exportation in lieu of destruction upon a showing by the owner that all of the conditions of section 381(e) of this title can and will be met. The provisions of this sentence shall not apply where condemnation is based upon violation of section 342(a)(1), (2), or (6), section 351(a)(3), section 352(j), or section 361(a) or (d) of this title. Where such exportation is made to the original foreign supplier, then subparagraphs (A) and (B) of section 381(e)(1) of this title and the preceding sentence shall not be applicable; and in all cases of exportation the bond shall be conditioned that the article shall not be sold or disposed of until the applicable conditions of section 381(e) of this title have been met. Any person seeking to export an imported article pursuant to any of the provisions of this subsection shall establish that the article was intended for export at the time the article entered commerce. Any article condemned by reason of its being an article [inserted: in violation of section 301(jjj) or an article ]which may not, under section 344 or 355 of this title, be introduced into interstate commerce, shall be disposed of by destruction.

(2) The provisions of paragraph (1) of this subsection shall, to the extent deemed appropriate by the court, apply to any equipment or other thing which is not otherwise within the scope of such paragraph and which is referred to in paragraph (2) of subsection (a).

(3) Whenever in any proceeding under this section, involving paragraph (2) of subsection (a), the condemnation of any equipment or thing (other than a drug) is decreed, the court shall allow the claim of any claimant, to the extent of such claimant’s interest, for remission or mitigation of such forfeiture if such claimant proves to the satisfaction of the court (i) that he has not committed or caused to be committed any prohibited act referred to in such paragraph (2) and has no interest in any drug referred to therein, (ii) that he has an interest in such equipment or other thing as owner or lienor or otherwise, acquired by him in good faith, and (iii) that he at no time had any knowledge or reason to believe that such equipment or other thing was being or would be used in, or to facilitate, the violation of laws of the United States relating to counterfeit drugs.

§ 334(f)–(g)

(e)–(f) unchanged ·

(2) The court to which such case was removed shall have the powers and be subject to the duties, for purposes of such case, which the court from which removal was made would have had, or to which such court would have been subject, if such case had not been removed.

(g) Administrative restraint; detention orders

(1) If during an inspection conducted under section [struck: 374][inserted: 704] of [struck: this title of ]a facility or a vehicle, a device, [struck: drug][inserted: cannabinoid hemp product], or tobacco product[inserted: ,] which the officer or employee making the inspection has reason to believe is adulterated or misbranded is found in such facility or vehicle, [inserted: or the officer or employee making the inspection has reason to believe the product is a prohibited cannabinoid product, ]such officer or employee may order the device, [struck: drug][inserted: cannabinoid hemp product], [inserted: prohibited cannabinoid hemp product, ]or tobacco product detained (in accordance with regulations prescribed by the Secretary) for a reasonable period which may not exceed twenty days unless the Secretary determines that a period of detention greater than twenty days is required to institute an action under subsection (a) or section [struck: 332 of this title][inserted: 302], in which case he may authorize a detention period of not to exceed thirty days. Regulations of the Secretary prescribed under this paragraph shall require that before a device, drug, or tobacco product may be ordered detained under this paragraph the Secretary or an officer or employee designated by the Secretary approve such order. A detention order under this paragraph may require the labeling or marking of a device, drug, or tobacco product during the period of its detention for the purpose of identifying the device, drug, or tobacco product as detained. Any person who would be entitled to claim a device, drug, or tobacco product if it were seized under subsection (a) may appeal to the Secretary a detention of such device, drug, or tobacco product under this paragraph. Within five days of the date an appeal of a detention is filed with the Secretary, the Secretary shall after affording opportunity for an informal hearing by order confirm the detention or revoke it.

(2)

(A) Except as authorized by subparagraph (B), a device, drug, or tobacco product subject to a detention order issued under paragraph (1) shall not be moved by any person from the place at which it is ordered detained until—

Rest of § 334 unchanged ·

21 U.S.C. § 348 Food additives

Couldn't place the change
More for 21 U.S.C. § 348
Read § 348Only this section

The bill's words for this section

  1. Not carried out:

    Section 409(a) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 348(a)) is amended by adding at the end of the matter following paragraph (3) the following: A food bearing or containing a cannabinoid hemp product that meets the requirements of chapter X shall not, by reason of bearing or containing such a cannabinoid hemp product, be considered adulterated under section 402(a)(1)..

    We can't read how this instruction is worded yet, so it isn't shown in the text.

    Technical detailno-pattern: adding at the end of the matter following paragraph (X) the following: QTEXT.

Step through the changes